Generative AI requires massive amounts of power and water, and the aging U.S. grid can’t handle the load

Thanks to the artificial intelligence boom, new data centers are springing up as quickly as companies…

European drug regulator rejects Alzheimer’s treatment Leqembi from Biogen, Eisai

European drug regulators on Friday rejected the Alzheimer’s treatment Leqembi from Biogen and Eisai, creating another…

Pfizer’s gene therapy for rare genetic bleeding disorder succeeds in late-stage trial

Kena Betancur | Corbis News | Getty Images Pfizer on Wednesday said its experimental gene therapy…

Op-ed: How well can AI chatbots mimic doctors in a treatment setting? We put 5 to the test

Dr. Scott Gottlieb is a physician and served as the 23rd Commissioner of the U.S. Food…

Brain implant patient says OpenAI’s tech helps him communicate with family

Mark using Synchron’s BCI  Courtesy: Synchron A 64-year-old named Mark has spent the last year learning…

Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use

A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London, Britain…

Musk says next Neuralink brain implant expected soon, despite issues with the first patient

Jonathan Raa | Nurphoto | Getty Images Elon Musk said Wednesday that his brain tech startup…

Investors want proof AI will aid drug discovery. Evidence may come in the second half

As investors peer into the future to envision which industries are ripe to be reshaped and…

Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition

A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October…

FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.

A sign with the company logo sits outside of the headquarters campus of Eli Lilly and…

Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City…

Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year

Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the…

The best-funded generative AI startups in Europe have something in common: Big Tech experience

French founder of artificial intelligence startup Mistral AI, Arthur Mensch, attends the Viva Technology show at…

FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections

Zoom In IconArrows pointing outwards Merck’s new pneumococcal vaccine. Courtesy: Merck The Food and Drug Administration…

Moderna’s combination Covid, flu vaccine is more effective than existing shots in late-stage trial

Moderna on Monday said its combination vaccine that targets both Covid-19 and the flu was more…

Newseum Global